Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LAINE HIGA

Eye and Vision Services Providers Optometrist

NPI
1407262520
CMS profile
573654
Location
PHILADELPHIA, PA

General Payments · PY2018–2024

$7,280.92

  • Reported across 71 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$629.76

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $629.76 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
SUN PHARMACEUTICAL INDUSTRIES INC. $156.40 5
Harrow Eye, LLC $124.00 1
Dompe US, Inc. $119.62 2
Oyster Point Pharma, Inc. $117.00 1
ABBVIE INC. $52.22 2
GLAUKOS CORPORATION $40.91 1
BIOTISSUE HOLDINGS INC. $19.61 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,216.05 11
PY2019 $1,280.38 13
PY2020 $208.14 5
PY2021 $2,076.47 8
PY2022 $1,536.47 13
PY2023 $333.65 8
PY2024 $629.76 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $27.11 05/18/2024 Food and Beverage Undisputed 01/23/2026 1103916425 CMS
ABBVIE INC. $25.11 09/05/2024 Food and Beverage Undisputed 01/23/2026 1103916427 CMS
BIOTISSUE HOLDINGS INC. $19.61 08/19/2024 Food and Beverage Undisputed 01/23/2026 1148764922 CMS
Dompe US, Inc. $29.10 08/26/2024 Food and Beverage Undisputed 01/23/2026 1151408983 CMS
Dompe US, Inc. $90.52 10/17/2024 Food and Beverage Undisputed 01/23/2026 1151408985 CMS
Glaukos Corporation $40.91 12/04/2024 Food and Beverage Undisputed 01/23/2026 1151991455 CMS
Harrow Eye, LLC $124.00 06/27/2024 Food and Beverage Undisputed 01/23/2026 1145604936 CMS
Oyster Point Pharma, Inc. $117.00 01/22/2024 Food and Beverage Undisputed 01/23/2026 1147431669 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $43.00 06/21/2024 Food and Beverage Undisputed 01/23/2026 1152171812 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $35.32 06/21/2024 Food and Beverage Undisputed 01/23/2026 1153994116 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $31.46 07/22/2024 Food and Beverage Undisputed 01/23/2026 1152171806 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $27.91 09/11/2024 Food and Beverage Undisputed 01/23/2026 1152171810 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $18.71 11/08/2024 Food and Beverage Undisputed 01/23/2026 1152171808 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.